Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
15 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
14 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the press release related to the full year 2021 financial results
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the full year 2021 financial results presentation
|
Download |
|
23 Feb 2022 |
About corporate governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
22 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 March and 21 March 2024
|
Download |
|
15 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 8 March and 14 March 2024
|
Download |
|
12 Mar 2024 |
On business and financial situation |
ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
|
Download |
|
08 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 1 March and 7 March 2024
|
Download |
|
07 Mar 2024 |
On corporate transactions |
ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
04 Apr 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the first quarter of 2019
|
Download |
|
19 Mar 2019 |
R&D: new licenses, patents and registered trademarks |
ROVI Announces Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia
|
Download |
|
26 Feb 2019 |
Informe Anual de Remuneraciones de los Consejeros |
ROVI releases the 2018 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
26 Feb 2019 |
Informe Anual de Gobierno Corporativo |
ROVI releases the 2018 Annual Corporate Governance Report
|
Download |
|
26 Feb 2019 |
Otros sobre gobierno corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
